Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001046724 | SCV001210638 | uncertain significance | Fanconi anemia | 2021-08-13 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with glycine at codon 257 of the FANCG protein (p.Arg257Gly). The arginine residue is weakly conserved and there is a moderate physicochemical difference between arginine and glycine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in individual(s) with FANCG-related conditions (Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Center for Genomic Medicine, |
RCV001283830 | SCV004806135 | likely pathogenic | Fanconi anemia complementation group G | 2024-03-25 | criteria provided, single submitter | clinical testing | |
Biochemical Molecular Genetic Laboratory, |
RCV001283830 | SCV001469250 | uncertain significance | Fanconi anemia complementation group G | 2021-09-06 | no assertion criteria provided | clinical testing |